Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WHO DOES #2 WORK FOR?!
Yup. See ya.
So smart and clever. BWAHAHAHAHA.
Good call. This is too orchestrated. Better to let the dust settle.
Good for you!
Unless it’s done on purpose, lol.
Khoso Clinton.
FDA has 60’days to decide on LPAD after written request has been made. Any indication this was part of the meeting? Khoso doesn’t really seem to articulate very well.
Been a good week for Clay!
Yep
Love me some knuckleheads! Was able to move some March $2.50s and pick up 250 June $2.50s.
Nothing has changed. FDA has 60 days from whenever the meeting with CRMD took place to approve LPAD. Approval means commercialization.
Also, I still think BO or partnership incoming. This only strengths the argument, imo.
Annoying day. Let’s hope news one of these days. I thought maybe news had leaked. Boo.
At least you keep the streak alive. Well played!
Good luck to you.
Yeah I’d like to have FDA news.
I would not complain. Not one bit. News would be nice to sustain the PPS move.
GLTYA
Giddy up! Happy trading!
Fingers crossed indeed!!!
TALLY HO!!!
LoL. At least this thread has a good sense of humor while we wait for CRMD to sprout!
Good luck all!!!
LOVE IT.
Haha. What was that?! Lol
No China deal? Hey crackhead Bob, who or what are you talking about?
LoL. No worries. I am hoping this is the calm before the store. And hopefully the storm pours rainbows and unicorns with lightening bolts made from candy canes.
EOM.
Good point. One thought: LPAD requests, as I understand through my reading, require (or at least it’s highly suggested) regular contact with the FDA during the entire process. And because it’s an entirely new regulatory construct, I have to believe they have been back and forth with some frequency going back to early 2018.
That’s why I believe we’re likelier to hear something sooner rather than later, and that the outcome of the FDA meeting may have a substantial outcome for CRMD.
As Big Pharma, do you wait, do you hedge or so you go all in? At this point, I think there is significant premium based on the full dataset. Granted it’s the FDA and nothing is a lock—nor should there be—but this is about as close as they come.
More telling, IMO, is the BOD stock awards in January. They were the earliest ever issued but most importantly, they are the first that grant flexibility for Board members to exercise 1/12 of the award each month. This isn’t the same language included in the option grants to the C Suite folks—their awards are still only exercisable at the end of each year.
That telegraphs, at least to me, that the entire Board is in play, and that some here today may not be here in 1 month, 2 months, 3 months, etc; while the C Suite folks are the intellectual capital needed by Big Pharma to guide Neutrolin to market.
Coupled with the filing from Elliot on 3 Jan, which has some peculiar language with an end date 30 April 2019, I am hopeful something gets done near term.
Anyways, none of my jibber jabber really means anything—what will happen will happen. But boy is it fun to speculate!
Happy trading today!
I think they cleared Gelbfish as part of a deal. I think one (or more) smart Big Pharma have been lurking in the background since at least the July 25 interim analysis.
I believe everything is going to be announced at once...or in a quick cluster.
How’s that for betting the farm, lol.
I don’t have a peppercorn of inside knowledge. All I have is common sense: If I’m one of the Lords of Heparin, in a pharma vertical worth BILLIONS annually, I don’t let a cute and fuzzy lion cub run and tumble all over my turf without realizing it’s a clear and present danger to me.
You can’t kill it, so you adopt it, in one form or another (BO or partnership).
And if that hasn’t happened by now, then Big Pharma collectively have breached their duty to their shareholders, imo.
Khoso also indicated on 1.16 PR that BOD update was “near future”. That is a particularly juicy piece of info!
Good luck to you.
Agreed. And I wonder what the over/under is for a German court ruling on the McDowell’s matter (aka Tauropharm) near term.
Not a significant anticipated catalyst, but gosh that would be a cherry on top.
Thank you, kind sir. It looks as if everyone who has interest has taken a position and it’s now out of our collective hands.
I hope the hard work Khoso and team, alongside his brother Chevy Chase, pays off. With those numbers, I have to believe we’re good!!!
LOL.
Happy Wednesday!
I hear ya! I just hope before March 15, lol. Though I am rolling a bunch of calls to June.
Good luck my friend!
GRRRR. Some days. Then again, consolidation is good, right?
Haaaaa. Good to hear from you!!! CRMD will be the ticket! What a story from last April & May. Certainly makes up for that other cluster.
Passport at the ready!
Agreed. I actually thought we might hear back from FDA as early as 8 February. I believe they did have a meeting with the FDA, but my timing was too aggressive. I think before end of February is very possible.
Of course the rise the past week makes me wonder if news may be here sooner than people think.
Fingers crossed and GLTY.
OS 5 billion yet? It will be by EOY.
On E*TRADE pro, go to tools, market depth, click find symbol, enter crmd. Once it is located, go to Type and select options.
Now you have real time options at your finger tips.
Getting a little salty though. The price on March $2.50’s seem to suppressed. Let’s hope more great news is right around the corner for this gem.
I don’t know. I use E*TRADE and selection options with their ticker.
Sorry I can’t be of more help.
Let’s do this!
Long week. Bummer.
Fingers crossed! GLTY.
I’d be happy with anything slightly over $2.50 strike. LOL.
You think we hear anything in Q1? My magic 8 ball says before Valentines Day. But I’m likely wrong as usual. Lol.